Unlocking Scalable Oligonucleotide Manufacturing, Driving Commercial Success With Asymchem's Multi-Platform Solutions

As oligonucleotide therapeutics expand into larger indications and more complex modalities, scalable, cost-effective manufacturing has become a defining challenge for commercial success. This webinar explores how multi-platform strategies are redefining production, combining solid-phase, liquid-phase, and chemoenzymatic synthesis to improve throughput, control impurities, and reduce cost and environmental impact.

It highlights advances in reactor-based solid-phase technologies, tag-assisted liquid-phase methods, and enzymatic ligation approaches that enable high-fidelity assembly at scale. The discussion also addresses critical considerations beyond synthesis, including integrated CMC services, regulatory readiness, and supply chain resilience needed to support late-stage development and commercialization. With growing demand for robust, flexible manufacturing solutions, these innovations offer a clear path toward reliable, large-scale production.

Watch the full webinar to learn how evolving platforms are shaping the future of oligonucleotide manufacturing.